As Ebola cases rise in Congo and Uganda, vaccine developers are accelerating efforts to combat the rare Bundibugyo strain. IAVI CEO Mark Feinberg says a candidate vaccine could enter human trials by year-end. (Source: Bloomberg)
As Ebola cases rise in Congo and Uganda, vaccine developers are accelerating efforts to combat the rare Bundibugyo strain. IAVI CEO Mark Feinberg says a candidate vaccine could enter human trials by year-end. (Source: Bloomberg)
<iframe src="https://statesidedaily.com/embed/cluster/dbf0410320350e0dbf95e826501feac8cf44980e" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Ebola Vaccine Trials Could Start This Year"></iframe>
